BlueLinx Reports Q1 Net Loss and Negative EPS Despite Sales Growth
BXC is trading near its 52-week low of $44.78 (3.2% above the low) on elevated volume (2.7× avg).
Summary
BlueLinx Holdings Inc. reported a net loss of $1.5 million and a loss per share of $0.18 for Q1 2026, a significant decline from prior year's net income, despite a 3.1% increase in net sales and a 20% rise in Adjusted EBITDA.
Key Events · Earnings and Guidance · BXC
-
Net Loss Reported
The company swung to a net loss of $1.5 million ($0.18 loss per share) in Q1 2026, compared to a net income of $2.8 million ($0.33 per diluted share) in Q1 2025.
-
Sales Growth Achieved
Net sales increased 3.1% year-over-year to $731 million, driven by specialty product sales and the Disdero acquisition.
-
Adjusted EBITDA Improved
Adjusted EBITDA rose 20% to $23.5 million, with Adjusted EBITDA margin expanding to 3.2% from 2.8% in the prior year.
-
Negative Cash Flow Worsened
Net cash used in operating activities increased to $57 million, and free cash flow was $(60) million, indicating higher cash burn compared to the prior year.
Analysis · BXC · Trade & Services
BlueLinx Holdings Inc.'s Q1 2026 results present a mixed picture, with operational improvements in net sales and Adjusted EBITDA, but a concerning swing to a GAAP net loss and negative diluted EPS. This follows a challenging fiscal 2025 where net income and EPS collapsed. While specialty product sales and gross margins showed strength, the overall GAAP profitability deteriorated, and cash flow from operations remained significantly negative. The market may focus on the GAAP loss and increased cash burn, especially with the stock trading near its 52-week low, despite the positive Adjusted EBITDA growth. Investors should monitor the company's ability to return to GAAP profitability and improve cash generation in subsequent quarters.
At the time of this filing, BXC was trading at $46.22 on NYSE in the Trade & Services sector, with a market capitalization of approximately $363.4M. The 52-week trading range was $44.78 to $88.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.